Back to Ss-31 research
ss-31 mitochondrial peptide review 2026-04-03 PubMed

Elamipretide: A Mitochondrial-Targeting Peptide with Broad Therapeutic Promise

Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.

Background

Mitochondrial dysfunction is a fundamental driver in the pathogenesis of numerous debilitating conditions, including cardiovascular disease, chronic kidney disease, and various neurodegenerative disorders. These vital cellular powerhouses, when compromised, lead to impaired energy production, increased oxidative stress, and cellular damage, contributing to disease progression. Despite extensive research, effective therapies directly targeting mitochondrial health remain limited. This review synthesizes current knowledge on Elamipretide, a unique peptide designed to restore mitochondrial function, addressing how its unique structure and mechanism of action contribute to its diverse therapeutic potential across multiple organ systems.


ss-31 mitochondrial peptide oxidative-stress
Source: pubmed:39940712 · Ingested 2026-04-03 · Digest: gemini-2.5-flash